| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.46 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |